Mediconf Diabetes Study Morning

12th Oct 2018 FREE
3 hrs cpd
To provide delegates with increased awareness of Type 2 Diabetes as a Cardiovascular (CV) Disease; assessing CV risk; reviewing current glucose lowering therapies and interventions and considering tools that may help convey to patient both CV risk and benefits of intervention. We will review the most recent evidence around our currently available glucose lowering therapies in respect of CV profile and consider benefits of individualised and combination therapies to optimise patient outcomes
Learning Outcomes
Following this session, delegates will be able to:
Describe a clearer understanding of current glucose lowering therapies, pro’s and con’s of
each therapy and increased awareness of and confidence in decision making around the
next most appropriate intervention.
Detail the latest evidence supporting glucose lowering therapy use, particularly in respect of
CV profile.
Consider the potential benefit of composite CV endpoints and targeting in diabetes.
More confidently present patients with appropriate treatment options for glucose lowering.
Employ a range of behavioural, motivational strategies that may help patients arrive at a
helpful risk / benefit appraisal and be more willing to accept intervention.
Clinical Outcomes
It is anticipated that that following this session, delegates will achieve:
Be better able to discuss with patients, the vascular nature of their diabetes, risk and benefits
of intervention.
By appropriate use of glucose lowering and other CV protective agents, to help achieve
composite CV targets and so improve patient cardiovascular outcomes.
Agenda
12
Oct
Registration, Coffee and Exhibition
09:00 - 09:30
12
Oct
Diabetes Management - Part 1 • ‘What’s New?’ • Review of the ADA / EASD 2018 Type 2 Diabetes Guidance • Overview of the Glucose Lowering Therapies and Consideration of CV benefit or Risk
09:30 - 11:00
12
Oct
Coffee, Biscuits and Exhibition
11:00 - 11:30
12
Oct
Diabetes Management - Part 2 • Cases: Assessing Risk; Appropriate Intervention; Effective Communication
11:30 - 13:00
Speakers
Mr Paul Dromgoole
Paul has extensive experience of supporting General Practice in clinical decision making and best
practice in diabetes management and his teaching sessions and workshops are consistently highly
evaluated for their clinical content, delivery and application to ‘real-life’ clinical practice.
Location
Additional information
Endocrinology and Diabetes
General Practice (GP)
Primary Care
Consultant
Foundation Year Doctor
General Practitioner (Locum)
General Practitioner (Partner)
General Practitioner (Salaried)
GP Registrar
Medical Student
Specialist Registrar
Specialist Trainee Doctor
Organiser reviews
No reviews for this course provider yet
Simply CPD is a product of Oppia Limited,
The TechnoCentre,
Coventry University Technology Park,
Puma Way Coventry CV1 2TT
Built with support from: